Proteomics Conjures Up Clinical Insights
When the Proteome Is Subjected to Analysis, It May Reveal Meaningful Patterns
Top 15 Bioprocessing Companies
Manufacturing Grows Along with the Development of Biologics
Reactivating a Dormant X
A New Strategy to Treat Rett Syndrome, which Occurs Almost Exclusively in Girls
Tumor Biomarkers Culled from Errant Transcripts
Potential for Blood Platelet–Derived Biomarkers to ID and Locate Tumors
For full access to this article login to GEN Select now.
Getting a Handle on Nanobiotech Products
Regulators and Companies Are Laying the Groundwork for a Predicted Bright Future
- As the regulatory pathway to approval for biotech products becomes more arduous, lengthy, and expensive, biofirms are fighting to keep pace with a rapidly changing regulatory landscape. They also are trying to find out how the FDA is going to look at nanotechnology product development. A number of biotech ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.